Lineage Cell Therapeutics, Inc. SEC filings LCTX
Lineage Cell Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jul 3, 2012. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2026 | — |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 12, 2026 | Jun 9, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Apr 29, 2026 |
| EFFECT | Filing | Mar 23, 2026 | — |
| CORRESP | Letter to the SEC | Mar 19, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2026 | — |
| 4 | Insider transaction | Mar 12, 2026 | Mar 12, 2026 |
| S-3 | Shelf registration | Mar 11, 2026 | — |
| 8-K |
Current report
Other events
|
Mar 11, 2026 | Mar 11, 2026 |
| 424B5 | Prospectus supplement | Mar 11, 2026 | — |
| 4 | Insider transaction | Mar 6, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 5, 2026 |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Dec 19, 2025 | Dec 19, 2025 |
| 4 | Insider transaction | Dec 19, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Other events
|
Nov 28, 2025 | Nov 28, 2025 |
| 8-K |
Current report
Other events
|
Nov 24, 2025 | Nov 20, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 14, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 12, 2025 | Nov 12, 2025 |
| 424B3 | Prospectus | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 26, 2025 | — |
| 144 | Notice of proposed sale | Sep 24, 2025 | — |
| 144 | Notice of proposed sale | Sep 10, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 26, 2025 | Aug 26, 2025 |
| S-8 | Employee stock plan registration | Aug 15, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 17, 2025 | — |
| 4 | Insider transaction | Jul 3, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jul 1, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jul 2, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 23, 2025 | Jun 23, 2025 |
| DEFA14A | Additional proxy material | Jun 11, 2025 | — |
| 8-K |
Current report
Auditor change
|
Jun 9, 2025 | Jun 3, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Other events
|
May 1, 2025 | May 1, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 26, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 24, 2025 | — |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 10-K | Annual report | Mar 10, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Feb 12, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 12, 2025 | Feb 11, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 28, 2025 | — |
| 4 | Insider transaction | Jan 28, 2025 | Jan 27, 2025 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure, Other events
|
Jan 27, 2025 | Jan 27, 2025 |
| DEF 14A | Proxy statement | Dec 9, 2024 | Dec 9, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 29, 2024 | Nov 29, 2024 |
| 4 | Insider transaction | Nov 26, 2024 | Nov 26, 2024 |
| 4 | Insider transaction | Nov 26, 2024 | Nov 26, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 22, 2024 | Nov 21, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 21, 2024 | — |
| 424B5 | Prospectus supplement | Nov 21, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Nov 20, 2024 | Nov 19, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| 4 | Insider transaction | Aug 19, 2024 | Aug 16, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 8-K |
Current report
Auditor change
|
Jun 14, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | May 28, 2024 | May 24, 2024 |
| EFFECT | Filing | May 14, 2024 | — |
| 8-K |
Current report
Other events
|
May 14, 2024 | May 14, 2024 |
| 424B5 | Prospectus supplement | May 14, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Apr 29, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 11, 2024 |
| 424B5 | Prospectus supplement | Mar 22, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 22, 2024 | Mar 12, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 7, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 7, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 7, 2024 |
| S-3 | Shelf registration | Mar 7, 2024 | — |
| 10-K | Annual report | Mar 7, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 7, 2024 | Mar 7, 2024 |
| 8-K |
Current report
Other events
|
Feb 15, 2024 | Feb 14, 2024 |
| 4 | Insider transaction | Feb 12, 2024 | Feb 11, 2024 |
| 4 | Insider transaction | Feb 12, 2024 | Feb 11, 2024 |
| 4 | Insider transaction | Feb 8, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 8, 2024 | Feb 6, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Feb 8, 2024 | — |
| 424B5 | Prospectus supplement | Feb 6, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Feb 6, 2024 | Feb 6, 2024 |
| 424B5 | Prospectus supplement | Feb 6, 2024 | — |
| 4 | Insider transaction | Jan 2, 2024 | Dec 29, 2023 |
| S-8 | Employee stock plan registration | Nov 13, 2023 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 7, 2023 | Sep 6, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| ARS | Annual report to shareholders | Jul 27, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Jul 27, 2023 | — |
| DEF 14A | Proxy statement | Jul 27, 2023 | Jul 27, 2023 |
| PRE 14A | Preliminary proxy statement | Jul 11, 2023 | Jul 11, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jul 1, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jul 1, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jul 1, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jul 1, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jul 1, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jul 1, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jul 1, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jul 1, 2023 |
| 8-K |
Current report
Other events
|
Jun 21, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Other events
|
May 18, 2023 | May 18, 2023 |
| 424B5 | Prospectus supplement | May 18, 2023 | — |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 10-K/A | Amended annual report | Apr 27, 2023 | Dec 31, 2022 |
| 4 | Insider transaction | Mar 10, 2023 | Mar 9, 2023 |
| 4 | Insider transaction | Mar 10, 2023 | Mar 9, 2023 |
| 4 | Insider transaction | Mar 10, 2023 | Mar 9, 2023 |
| 4 | Insider transaction | Mar 10, 2023 | Mar 9, 2023 |
| 10-K | Annual report | Mar 9, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 5 | Annual insider ownership | Feb 14, 2023 | Dec 31, 2022 |
| 4 | Insider transaction | Feb 14, 2023 | Feb 11, 2023 |
| 4 | Insider transaction | Feb 14, 2023 | Feb 11, 2023 |
| 4 | Insider transaction | Feb 14, 2023 | Feb 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 23, 2023 | Jan 23, 2023 |
| 4 | Insider transaction | Nov 16, 2022 | Nov 14, 2022 |
| 3 | Initial insider ownership | Nov 16, 2022 | Nov 14, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Oct 31, 2022 | Oct 28, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 28, 2022 | Oct 26, 2022 |
| 8-K/A |
Amended current report
Officer or director change
|
Sep 30, 2022 | Sep 20, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 26, 2022 | Sep 20, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 3 | Initial insider ownership | Jul 8, 2022 | Jul 7, 2022 |
| SC 13G | Ownership over 5% (passive) | Jul 8, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Jul 7, 2022 | Jul 5, 2022 |
| 4 | Insider transaction | Jul 6, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jul 6, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jul 6, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jul 6, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jul 6, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jul 6, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jul 6, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jul 6, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jun 30, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2022 | Jun 16, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 12, 2022 | May 11, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Apr 29, 2022 |
| 4 | Insider transaction | Apr 4, 2022 | Mar 31, 2022 |
| 4 | Insider transaction | Mar 29, 2022 | Mar 28, 2022 |
| 4 | Insider transaction | Mar 28, 2022 | Mar 25, 2022 |
| 4 | Insider transaction | Mar 25, 2022 | Mar 23, 2022 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 25, 2022 | — |
| 4 | Insider transaction | Mar 25, 2022 | Mar 24, 2022 |
| 4 | Insider transaction | Mar 11, 2022 | Mar 10, 2022 |
| 4 | Insider transaction | Mar 11, 2022 | Mar 10, 2022 |
| 4 | Insider transaction | Mar 11, 2022 | Mar 10, 2022 |
| 4 | Insider transaction | Mar 11, 2022 | Mar 10, 2022 |
| 10-K | Annual report | Mar 10, 2022 | Dec 31, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- LCTX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- CA
- Headquarters
- Carlsbad, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 876343
- Former names
- BIOTIME INC (until Aug 8, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.